 | • レポートコード：QYR9NV02500 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、化学療法による好中球減少薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、F-627、BBT-018、フィルグラスチム、GW-003、NLA-101、その他に、用途別には、病院、診療所、その他にセグメント区分し、化学療法による好中球減少薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・化学療法による好中球減少薬の世界市場概要 ・化学療法による好中球減少薬の製造コスト構成分析 ・化学療法による好中球減少薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・化学療法による好中球減少薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・化学療法による好中球減少薬のセグメント分析（種類別） （F-627、BBT-018、フィルグラスチム、GW-003、NLA-101、その他） ・化学療法による好中球減少薬のセグメント分析（用途別） （病院、診療所、その他） ・化学療法による好中球減少薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （BeyondSpring Pharmaceuticals Inc、Biocon Ltd、Bolder Biotechnology Inc、Cellerant Therapeutics Inc、Chong Kun Dang Pharmaceutical Corp、Cinfa Biotech SL、Dr. Reddy's Laboratories Ltd、Gene Techno Science Co Ltd、Generon (Shanghai) Corp Ltd、Genexine Inc、GlycoMimetics Inc、Hanmi Pharmaceuticals Co Ltd、Intas Pharmaceuticals Ltd、Lupin Ltd、Mycenax Biotech Inc、Myelo Therapeutics GmbH、Nohla Therapeutics Inc、Octapharma AG、Pangen Biotech Inc.、Pfenex Inc、） ・化学療法による好中球減少薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Chemotherapy Induced Neutropenia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Chemotherapy Induced Neutropenia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chemotherapy Induced Neutropenia Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chemotherapy Induced Neutropenia Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chemotherapy Induced Neutropenia Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
BeyondSpring Pharmaceuticals Inc
Biocon Ltd
Bolder Biotechnology Inc
Cellerant Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Cinfa Biotech SL
Dr. Reddy’s Laboratories Ltd
Gene Techno Science Co Ltd
Generon (Shanghai) Corp Ltd
Genexine Inc
GlycoMimetics Inc
Hanmi Pharmaceuticals Co Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Mycenax Biotech Inc
Myelo Therapeutics GmbH
Nohla Therapeutics Inc
Octapharma AG
Pangen Biotech Inc.
Pfenex Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
F-627
BBT-018
Filgrastim
GW-003
NLA-101
Others
Segment by Application
Hospital
Clinic
Others
Table of Contents
Executive Summary
1 Industry Overview of Chemotherapy Induced Neutropenia Drug
1.1 Definition of Chemotherapy Induced Neutropenia Drug
1.2 Chemotherapy Induced Neutropenia Drug Segment by Type
1.2.1 Global Chemotherapy Induced Neutropenia Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 F-627
1.2.3 BBT-018
1.2.4 Filgrastim
1.2.5 GW-003
1.2.6 NLA-101
1.2.7 Others
1.3 Chemotherapy Induced Neutropenia Drug Segment by Applications
1.3.1 Global Chemotherapy Induced Neutropenia Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chemotherapy Induced Neutropenia Drug Overall Market
1.4.1 Global Chemotherapy Induced Neutropenia Drug Revenue (2014-2025)
1.4.2 Global Chemotherapy Induced Neutropenia Drug Production (2014-2025)
1.4.3 North America Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
1.4.4 Europe Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
1.4.5 China Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
1.4.6 Japan Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
1.4.8 India Chemotherapy Induced Neutropenia Drug Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Chemotherapy Induced Neutropenia Drug
2.3 Manufacturing Process Analysis of Chemotherapy Induced Neutropenia Drug
2.4 Industry Chain Structure of Chemotherapy Induced Neutropenia Drug
3 Development and Manufacturing Plants Analysis of Chemotherapy Induced Neutropenia Drug
3.1 Capacity and Commercial Production Date
3.2 Global Chemotherapy Induced Neutropenia Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Chemotherapy Induced Neutropenia Drug
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Chemotherapy Induced Neutropenia Drug Production and Capacity Analysis
4.2 Chemotherapy Induced Neutropenia Drug Revenue Analysis
4.3 Chemotherapy Induced Neutropenia Drug Price Analysis
4.4 Market Concentration Degree
5 Chemotherapy Induced Neutropenia Drug Regional Market Analysis
5.1 Chemotherapy Induced Neutropenia Drug Production by Regions
5.1.1 Global Chemotherapy Induced Neutropenia Drug Production by Regions
5.1.2 Global Chemotherapy Induced Neutropenia Drug Revenue by Regions
5.2 Chemotherapy Induced Neutropenia Drug Consumption by Regions
5.3 North America Chemotherapy Induced Neutropenia Drug Market Analysis
5.3.1 North America Chemotherapy Induced Neutropenia Drug Production
5.3.2 North America Chemotherapy Induced Neutropenia Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Chemotherapy Induced Neutropenia Drug Import and Export
5.4 Europe Chemotherapy Induced Neutropenia Drug Market Analysis
5.4.1 Europe Chemotherapy Induced Neutropenia Drug Production
5.4.2 Europe Chemotherapy Induced Neutropenia Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Chemotherapy Induced Neutropenia Drug Import and Export
5.5 China Chemotherapy Induced Neutropenia Drug Market Analysis
5.5.1 China Chemotherapy Induced Neutropenia Drug Production
5.5.2 China Chemotherapy Induced Neutropenia Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Chemotherapy Induced Neutropenia Drug Import and Export
5.6 Japan Chemotherapy Induced Neutropenia Drug Market Analysis
5.6.1 Japan Chemotherapy Induced Neutropenia Drug Production
5.6.2 Japan Chemotherapy Induced Neutropenia Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Chemotherapy Induced Neutropenia Drug Import and Export
5.7 Southeast Asia Chemotherapy Induced Neutropenia Drug Market Analysis
5.7.1 Southeast Asia Chemotherapy Induced Neutropenia Drug Production
5.7.2 Southeast Asia Chemotherapy Induced Neutropenia Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Chemotherapy Induced Neutropenia Drug Import and Export
5.8 India Chemotherapy Induced Neutropenia Drug Market Analysis
5.8.1 India Chemotherapy Induced Neutropenia Drug Production
5.8.2 India Chemotherapy Induced Neutropenia Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Chemotherapy Induced Neutropenia Drug Import and Export
6 Chemotherapy Induced Neutropenia Drug Segment Market Analysis (by Type)
6.1 Global Chemotherapy Induced Neutropenia Drug Production by Type
6.2 Global Chemotherapy Induced Neutropenia Drug Revenue by Type
6.3 Chemotherapy Induced Neutropenia Drug Price by Type
7 Chemotherapy Induced Neutropenia Drug Segment Market Analysis (by Application)
7.1 Global Chemotherapy Induced Neutropenia Drug Consumption by Application
7.2 Global Chemotherapy Induced Neutropenia Drug Consumption Market Share by Application (2014-2019)
8 Chemotherapy Induced Neutropenia Drug Major Manufacturers Analysis
8.1 BeyondSpring Pharmaceuticals Inc
8.1.1 BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.1.2 BeyondSpring Pharmaceuticals Inc Product Introduction, Application and Specification
8.1.3 BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biocon Ltd
8.2.1 Biocon Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.2.2 Biocon Ltd Product Introduction, Application and Specification
8.2.3 Biocon Ltd Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bolder Biotechnology Inc
8.3.1 Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.3.2 Bolder Biotechnology Inc Product Introduction, Application and Specification
8.3.3 Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cellerant Therapeutics Inc
8.4.1 Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.4.2 Cellerant Therapeutics Inc Product Introduction, Application and Specification
8.4.3 Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Chong Kun Dang Pharmaceutical Corp
8.5.1 Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.5.2 Chong Kun Dang Pharmaceutical Corp Product Introduction, Application and Specification
8.5.3 Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Cinfa Biotech SL
8.6.1 Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.6.2 Cinfa Biotech SL Product Introduction, Application and Specification
8.6.3 Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Dr. Reddy’s Laboratories Ltd
8.7.1 Dr. Reddy’s Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.7.2 Dr. Reddy’s Laboratories Ltd Product Introduction, Application and Specification
8.7.3 Dr. Reddy’s Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Gene Techno Science Co Ltd
8.8.1 Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.8.2 Gene Techno Science Co Ltd Product Introduction, Application and Specification
8.8.3 Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Generon (Shanghai) Corp Ltd
8.9.1 Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.9.2 Generon (Shanghai) Corp Ltd Product Introduction, Application and Specification
8.9.3 Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Genexine Inc
8.10.1 Genexine Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
8.10.2 Genexine Inc Product Introduction, Application and Specification
8.10.3 Genexine Inc Chemotherapy Induced Neutropenia Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 GlycoMimetics Inc
8.12 Hanmi Pharmaceuticals Co Ltd
8.13 Intas Pharmaceuticals Ltd
8.14 Lupin Ltd
8.15 Mycenax Biotech Inc
8.16 Myelo Therapeutics GmbH
8.17 Nohla Therapeutics Inc
8.18 Octapharma AG
8.19 Pangen Biotech Inc.
8.20 Pfenex Inc
9 Development Trend of Analysis of Chemotherapy Induced Neutropenia Drug Market
9.1 Global Chemotherapy Induced Neutropenia Drug Market Trend Analysis
9.1.1 Global Chemotherapy Induced Neutropenia Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Chemotherapy Induced Neutropenia Drug Regional Market Trend
9.2.1 North America Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.2.2 Europe Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.2.3 China Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.2.4 Japan Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.2.5 Southeast Asia Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.2.6 India Chemotherapy Induced Neutropenia Drug Forecast 2019-2025
9.3 Chemotherapy Induced Neutropenia Drug Market Trend (Product Type)
9.4 Chemotherapy Induced Neutropenia Drug Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Chemotherapy Induced Neutropenia Drug Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Chemotherapy Induced Neutropenia Drug
Table Global Chemotherapy Induced Neutropenia Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Chemotherapy Induced Neutropenia Drug Production Market Share by Types in 2018
Figure F-627 Product Picture
Figure BBT-018 Product Picture
Figure Filgrastim Product Picture
Figure GW-003 Product Picture
Figure NLA-101 Product Picture
Figure Others Product Picture
Table Global Chemotherapy Induced Neutropenia Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Chemotherapy Induced Neutropenia Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Chemotherapy Induced Neutropenia Drug Revenue (Million USD) (2014-2025)
Figure Global Chemotherapy Induced Neutropenia Drug Production (K Pcs) (2014-2025)
Figure North America Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Figure Europe Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Figure China Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Figure Japan Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Figure India Chemotherapy Induced Neutropenia Drug Market Size (Million USD) (2014-2025)
Table Chemotherapy Induced Neutropenia Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Chemotherapy Induced Neutropenia Drug in 2018
Figure Manufacturing Process Analysis of Chemotherapy Induced Neutropenia Drug
Figure Industry Chain Structure of Chemotherapy Induced Neutropenia Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Chemotherapy Induced Neutropenia Drug Manufacturing Plants Distribution
Table Chemotherapy Induced Neutropenia Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Chemotherapy Induced Neutropenia Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Chemotherapy Induced Neutropenia Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Chemotherapy Induced Neutropenia Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Chemotherapy Induced Neutropenia Drug Production Share by Manufacturers in 2018
Table Chemotherapy Induced Neutropenia Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Chemotherapy Induced Neutropenia Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Chemotherapy Induced Neutropenia Drug Revenue Share by Manufacturers in 2018
Table Chemotherapy Induced Neutropenia Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Chemotherapy Induced Neutropenia Drug Production by Regions 2014-2019 (K Pcs)
Table Global Chemotherapy Induced Neutropenia Drug Production Market Share by Regions 2014-2019
Figure Global Chemotherapy Induced Neutropenia Drug Production Market Share by Regions in 2018
Table Global Chemotherapy Induced Neutropenia Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Regions 2014-2019
Figure Global Chemotherapy Induced Neutropenia Drug Revenue Market Share by Regions in 2018
Table Global Chemotherapy Induced Neutropenia Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Chemotherapy Induced Neutropenia Drug Consumption Market Share by Regions 2014-2019
Figure North America Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure China Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure India Chemotherapy Induced Neutropenia Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Chemotherapy Induced Neutropenia Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Chemotherapy Induced Neutropenia Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Chemotherapy Induced Neutropenia Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Chemotherapy Induced Neutropenia Drug Market Share by Application (2014-2019)
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table BeyondSpring Pharmaceuticals Inc Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Biocon Ltd Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Biocon Ltd Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Bolder Biotechnology Inc Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Cellerant Therapeutics Inc Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Chong Kun Dang Pharmaceutical Corp Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Cinfa Biotech SL Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Dr. Reddy's Laboratories Ltd Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Gene Techno Science Co Ltd Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Generon (Shanghai) Corp Ltd Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Product Introduction, Application and Specification
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Production Growth Rate (2014-2019)
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Production Market Share (2014-2019)
Figure Genexine Inc Chemotherapy Induced Neutropenia Drug Revenue Market Share (2014-2019)
Table Genexine Inc Chemotherapy Induced Neutropenia Drug Main Business and Markets Served
Table GlycoMimetics Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Hanmi Pharmaceuticals Co Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Intas Pharmaceuticals Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Lupin Ltd Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Mycenax Biotech Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Myelo Therapeutics GmbH Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Nohla Therapeutics Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Octapharma AG Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Pangen Biotech Inc. Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Table Pfenex Inc Chemotherapy Induced Neutropenia Drug Production Sites and Area Served
Figure Global Chemotherapy Induced Neutropenia Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Chemotherapy Induced Neutropenia Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Chemotherapy Induced Neutropenia Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Chemotherapy Induced Neutropenia Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Chemotherapy Induced Neutropenia Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Chemotherapy Induced Neutropenia Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Chemotherapy Induced Neutropenia Drug by Application (2019-2025)
Table Chemotherapy Induced Neutropenia Drug Distributors List
Table Chemotherapy Induced Neutropenia Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
化学療法誘発吐き気および嘔吐薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy. Scope of the Report: This report focuses on the Chemotherapy-induced Nausea and Vomiting Drugs in global market, especiall…- 化学療法による吐き気および嘔吐（CINV）薬のグローバル市場調査 2019年 The global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs volume and value at global le…
- 化学療法ポンプのグローバル市場調査 2019年 The global Chemotherapy Pump market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotherapy Pump volume and value at global level, regional level and company level. From a global perspective, this rep…
- 化学療法輸液ポンプのグローバル市場調査 2019年 The global Chemotherapy Infusion Pump market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Chemotherapy Infusion Pump volume and value at global level, regional level and company level. From a global per…
- 予防的喘息治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The m…